Zenas BioPharma, Inc.
ZBIO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Operating Activities | – | – | – |
| Net Income | -$157 | -$37 | -$119 |
| Dep. & Amort. | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 |
| Stock-Based Comp. | $11 | $3 | $1 |
| Change in WC | $25 | -$8 | $8 |
| Other Non-Cash | $1 | $11 | $45 |
| Operating Cash Flow | -$120 | -$31 | -$66 |
| Investing Activities | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 |
| Inv. Purchases | -$36 | $0 | $0 |
| Inv. Sales/Matur. | $6 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | -$2 |
| Investing Cash Flow | -$31 | -$0 | -$2 |
| Financing Activities | – | – | – |
| Debt Repay. | $0 | $20 | $0 |
| Stock Issued | $241 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 |
| Other Fin. Act. | $172 | $0 | $59 |
| Financing Cash Flow | $413 | $20 | $59 |
| Forex Effect | $0 | $0 | -$0 |
| Net Chg. in Cash | $263 | -$10 | -$9 |
| Supplemental Information | – | – | – |
| Beg. Cash | $57 | $67 | $76 |
| End Cash | $320 | $57 | $67 |
| Free Cash Flow | -$120 | -$31 | -$68 |